Evrom Cannalytech

Cannabis-Specific Biostimulants Enhancing Yield and Disease Resistance​

Agriculture & Food Technologies
Active
Pre-Funding Petah Tikva Founded 2023
Total raised
Stage
Pre-Funding
Founded
2023
Headcount
2
HQ
Petah Tikva
Sector
Agriculture & Food Technologies

About

​Evrom Cannalytech is specializing in the development of biostimulants tailored specifically for cannabis cultivation. Their patent-pending formulations enhance disease resistance and increase the production of cannabinoids and terpenoids in both greenhouse and outdoor settings. By utilizing pathogen-derived compounds, these biostimulants activate the plant's defense mechanisms, leading to healthier growth and improved yields.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Evrom Cannalytech founded?
Evrom Cannalytech was founded in February 2023.
What is Evrom Cannalytech's primary focus?
Evrom Cannalytech specializes in developing biostimulants specifically for cannabis cultivation.
Where is Evrom Cannalytech headquartered?
Evrom Cannalytech is headquartered in Petah Tikva, Israel.
What is the current funding stage of Evrom Cannalytech?
Evrom Cannalytech is currently in the Pre-Funding stage.
What is the primary sector of Evrom Cannalytech?
Evrom Cannalytech's primary sector is Agriculture & Food Technologies.
How many employees does Evrom Cannalytech have?
Evrom Cannalytech has between 1 and 10 employees.
What is the core technology behind Evrom Cannalytech's biostimulants?
Evrom Cannalytech's biostimulants utilize pathogen-derived compounds to activate the plant's defense mechanisms, enhancing disease resistance and increasing cannabinoid and terpenoid production.
Who is a founder of Evrom Cannalytech?
Onie Tsabari is a founder of Evrom Cannalytech.

Sectors & technology

Primary sector
Agriculture & Food Technologies
Sub-sectors
Agriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Materials & Substances
Business model
B2B

Tags

medical-cannabisagtechbiotechnology